News
-
Superbug secret is out
Friday | May 19 2017AN INTERNATIONAL study led by Monash University has discovered the molecular mechanism by which the potentially deadly superbug 'Golden Staph' evades antibiotic treatment, providing the first important clues on how to counter superbug antibiotic resistance.
-
Probiotic success
Friday | May 19 2017PROBIOTIC supplementation with bifidobacterium lactis Bl-04 has been shown to help maintain healthy respiratory immune function in new research sponsored by DuPont and published in Beneficial Microbes - CLICK HERE.
-
US opioid crisis
Friday | May 19 2017AS THE US opioid abuse epidemic continues to claim lives at a rapid rate, the search for the heroin high is creating a dangerous situation for pharmacies, reports CNBC.
-
Tamper-evident code
Friday | May 19 2017THE TGA has released an updated code of practice for tamper-evident packaging of therapeutic goods, along with a consumer information page online at tga.gov.au.
-
WSMIGA registration open
Friday | May 19 2017THE World Self Medication Industry has opened registrations for its upcoming General Assembly 2017 (WSMIGA) which will be held in Sydney from 17-19 Oct 2017.
-
Review report submitted
Friday | May 19 2017THE long-awaited interim report from the Review of Pharmacy Remuneration and Regulation has been lodged with Health Minister Greg Hunt, with the Health Department last night telling PD it will be released publicly this financial year.
-
Dispensary Corner 18 May 17
Thursday | May 18 2017EFFISHIENT dentistry - a Russian professional deep sea diver has caused an online sensation after he allowed some fish to clean inside his mouth.
-
Draft ACMS decisions
Thursday | May 18 2017THE Therapeutic Goods Administration is proposing allowing advertising of emergency contraception drug ulipristal, with an Appendix H listing of the item one of the interim decisions by the Advisory Committee on Medicines Scheduling released yesterday.
-
Prozac pregnancy fail
Thursday | May 18 2017THE most commonly prescribed antidepressant, fluoxetine, sold as Prozac and other brands, has been linked to an increased risk of birth defects when used by pregnant women, according to a meta-analysis published in the British Journal of Clinical Pharmacology.